Livio Trentin

Livio Trentin is a notable inventor based in Susegana, Italy. He has made significant contributions to the field of medicinal chemistry, particularly in the development of antitumoral agents. His work focuses on innovative compounds that have the potential to treat various forms of cancer.

Latest Patents

Trentin holds a patent for a 1-phenylpropanone compound, which is described as having the formula (I). This compound includes specific elements where X can be CH or an atom selected from the group consisting of O, S, and Se. The integer n ranges from 4 to 6, and A is a substituent selected from a group that includes 4-morpholyl, 1-piperidinyl, and 4-methyl-1-piperazinyl. The invention is particularly aimed at its use as an antitumoral agent in the treatment of breast cancer, chronic lymphatic leukemia, or neuroblastoma. The patent also encompasses new 1-phenylpropanone compounds and their applications as antitumoral agents.

Career Highlights

Livio Trentin is affiliated with the Università Degli Studi Di Padova, where he conducts his research and development activities. His work has led to advancements in the understanding and treatment of cancer through innovative chemical compounds.

Collaborations

Trentin has collaborated with esteemed colleagues such as Giuseppe Zagotto and Anna Maria Brunati. These partnerships have contributed to the success and impact of his research in the field of medicinal chemistry.

Conclusion

Livio Trentin's contributions to the development of antitumoral compounds highlight his role as an important figure in the fight against cancer. His innovative work continues to pave the way for new treatments and therapies.

Profile summary based on public USPTO records.